Evidence map›Paper›PMID 25969552›Full record

ArticleJournal of experimental botany2015

Prolonged expression of the BX1 signature enzyme is associated with a recombination hotspot in the benzoxazinoid gene cluster in Zea mays.

Linlin Zheng, Michael D McMullen, Eva Bauer, Chris-Carolin Schön, Alfons Gierl, Monika Frey

Open access · bronzeAbstract read
In one paragraph

Article in Journal of experimental botany, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
10.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Hybrids reveal accessible chromatinbioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. The chromatin accessibility landscape during early maize seed development.The Plant journal : for cell and molecular biology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Root-exuded specialized metabolites reduce arsenic toxicity in maize.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Linlin ZhengLehrstuhl für Genetik, Wissenschaftszentrum Weihenstephan, Technische Universität München, 85354 Freising, Germany.
Michael D McMullenUSDA ARS, University of Missouri, Columbia, MO 65211, USA.
Eva BauerLehrstuhl für Pflanzenzüchtung, Wissenschaftszentrum Weihenstephan, Technische Universität München, 85354 Freising, Germany.
Chris-Carolin SchönLehrstuhl für Pflanzenzüchtung, Wissenschaftszentrum Weihenstephan, Technische Universität München, 85354 Freising, Germany.
Alfons GierlLehrstuhl für Genetik, Wissenschaftszentrum Weihenstephan, Technische Universität München, 85354 Freising, Germany.
Monika FreyLehrstuhl für Genetik, Wissenschaftszentrum Weihenstephan, Technische Universität München, 85354 Freising, Germany Monika.Frey@wzw.tum.de.
Technical University of Munich · DEUniversity of Missouri · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Benzoxazinoids represent preformed protective and allelopathic compounds. The main benzoxazinoid in maize (Zea mays L.) is 2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-one (DIMBOA). DIMBOA confers resistance to herbivores and microbes. Protective concentrations are found predominantly in young plantlets. We made use of the genetic diversity present in the maize nested association mapping (NAM) panel to identify lines with significant benzoxazinoid concentrations at later developmental stages. At 24 d after imbibition (dai), only three lines, including Mo17, showed effective DIMBOA concentrations of 1.5mM or more; B73, by contrast, had low a DIMBOA content. Mapping studies based on Mo17 and B73 were performed to reveal mechanisms that influence the DIMBOA level in 24 dai plants. A major quantitative trait locus mapped to the Bx gene cluster located on the short arm of chromosome 4, which encodes the DIMBOA biosynthetic genes. Mo17 was distinguished from all other NAM lines by high transcriptional expression of the Bx1 gene at later developmental stages. Bx1 encodes the signature enzyme of the pathway. In Mo17×B73 hybrids at 24 dai, only the Mo17 Bx1 allele transcript was detected. A 3.9kb cis-element, termed DICE (distal cis-element), that is located in the Bx gene cluster approximately 140 kb upstream of Bx1, was required for high Bx1 transcript levels during later developmental stages in Mo17. The DICE region was a hotspot of meiotic recombination. Genetic analysis revealed that high 24 dai DIMBOA concentrations were not strictly dependent on high Bx1 transcript levels. However, constitutive expression of Bx1 in transgenics increased DIMBOA levels at 24 dai, corroborating a correlation between DIMBOA content and Bx1 transcription.

Indexed as

Genes, PlantMultigene FamilyRecombination, GeneticAllelesBase PairingBenzoxazinesBiosynthetic PathwaysChromosome MappingChromosomes, PlantCrosses, GeneticGene Expression Regulation, PlantGenotypeInbreedingPlant ProteinsPlants, Genetically ModifiedPromoter Regions, Genetic2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-oneBenzoxazinesPlant ProteinsRNA, MessengerAllele-specific expressionbiosynthetic clustercis-elementdefenceDIMBOAQTL mappingsecondary metabolites.

Identifiers

PMID25969552
PMCPMC4473990
OpenAlexW2112483654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.